Randomized phase II study of two irinotecan schedules for patients with metastatic breast cancer refractory to an anthracycline, a taxane, or both

• PEREZ EA

収録刊行物

• J Clin Oncol.

  J Clin Oncol. 22 2849-2855, 2004

詳細情報

• CRID: 1570854175810547584
• NII論文ID: 10030230363
• データソース種別:
  • CiNii Articles